Login
$UTHR
$587.88 +$0.00 (0.0%) After hours

$UTHR SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.64M)

12 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.64M)

12 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.57M)

10 Nov 2026 Form 4: Rothblatt Martine A, Director

Sold 1,614 shares ($944K)

10 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 7,886 shares ($4.52M)

10 Nov 2026 Form 4: Patusky Christopher, Director

Received 1,210 shares by exercise or conversion ($160K) · Sold 1,210 shares ($702K)

09 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.36M)

09 Nov 2026 144
06 Nov 2026 Form 4: Rothblatt Martine A, Director

Sold 1,960 shares ($1.17M)

06 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 7,540 shares ($4.33M)

05 Nov 2026 Form 4: Rothblatt Martine A, Director

Sold 1,723 shares ($1.05M)

05 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 7,777 shares ($4.66M)

05 Nov 2026 Form 4: Mahon Paul A, EVP & GENERAL COUNSEL

Received 8,300 shares by exercise or conversion ($1.21M) · Sold 8,300 shares ($4.97M)

05 Nov 2026 144
04 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.72M)

04 Nov 2026 8-K: Results of Operations and Financial Condition

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., November 4, 2026: United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30, 2026. Total re...

04 Nov 2026 10-Q
03 Nov 2026 Form 4: Rothblatt Martine A, Director

Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.66M)

02 Nov 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support